These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25419059)

  • 1. Evaluation and Validation of Neo-Adjuvant Response Index (NRI) and It's Correlation with Various Predictive Biomarkers and RECIST in Locally Advanced Breast Cancer.
    Bamal R; Chintamani ; Tandon M; Mittal MK; Saxena S
    Indian J Surg Oncol; 2014 Sep; 5(3):171-7. PubMed ID: 25419059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Carcinoma Using Image-Guided Clip Placement.
    Pandurangappa V; Paruthy SB; Jamwal R; Singh A; Tanwar S; Kumar D; Pal S; Mohan SK; Das A; Trs PR
    Cureus; 2023 Oct; 15(10):e47763. PubMed ID: 38021852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma.
    Kunnuru SKR; Thiyagarajan M; Martin Daniel J; Singh K B
    Breast Cancer (Dove Med Press); 2020; 12():259-266. PubMed ID: 33262647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore.
    Steenbruggen TG; van Seijen M; Janssen LM; van Ramshorst MS; van Werkhoven E; Vrancken Peeters MTDF; Wesseling J; Lips EH; Sonke GS
    Clin Cancer Res; 2019 Aug; 25(16):4985-4992. PubMed ID: 31076546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
    Priyadarshini R; Raj GM; Kayal S; Ramesh A; Shewade DG
    J Clin Pharm Ther; 2019 Apr; 44(2):188-196. PubMed ID: 30637776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Subtypes As Emerging Predictors of Clinicopathological Response to Neoadjuvant Chemotherapy (NACT) in Locally Advanced Breast Cancer (LABC): A Single-Centre Experience in Western India.
    Sharma S; Rathore SS; Verma V; Kalyan M; Singh N; Irshad I
    Cureus; 2022 May; 14(5):e25229. PubMed ID: 35755569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
    Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
    Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
    Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
    J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients.
    Romero A; García-Sáenz JA; Fuentes-Ferrer M; López Garcia-Asenjo JA; Furió V; Román JM; Moreno A; de la Hoya M; Díaz-Rubio E; Martín M; Caldés T
    Ann Oncol; 2013 Mar; 24(3):655-61. PubMed ID: 23104719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple system for grading the response of breast cancer to neoadjuvant chemotherapy.
    Rodenhuis S; Mandjes IAM; Wesseling J; van de Vijver MJ; Peeters MTDFV; Sonke GS; Linn SC
    Ann Oncol; 2010 Mar; 21(3):481-487. PubMed ID: 19717533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neo-Adjuvant chemotherapy and its affects to the axilla-Can we safely downgrade axillary surgery to mirror the approach in the breast.
    Batt J; Chambers A; Al-Allak A; Vestey S; Hunt R; Massey E; Fowler C
    Breast J; 2020 Sep; 26(9):1667-1672. PubMed ID: 32767467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer--a prospective study.
    Chintamani ; Tandon M; Mishra A; Agarwal U; Saxena S
    World J Surg Oncol; 2011 Feb; 9():19. PubMed ID: 21396137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Soliman H; Wagner S; Flake DD; Robson M; Schwartzberg L; Sharma P; Magliocco A; Kronenwett R; Lancaster JM; Lanchbury JS; Gutin A; Gradishar W
    Ann Surg Oncol; 2020 Mar; 27(3):765-771. PubMed ID: 31907749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of response to neo-adjuvant chemotherapy in patients with locally advanced breast cancer with emphasis on pathological complete response.
    Narendra H; Thomas J; Ray S; Fernandes DJ
    Indian J Cancer; 2014; 51(4):587-92. PubMed ID: 26842205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo-adjuvant chemotherapy.
    Priyadarshini R; Raj GM; Sundaram R; Kayal S; Ramesh A; Shewade DG
    Breast Cancer; 2021 Mar; 28(2):414-423. PubMed ID: 33125673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).
    Agrawal S; Banswal L; Saha A; Arun I; Datta SS; Chatterjee S; Ahmed R
    Indian J Surg Oncol; 2016 Dec; 7(4):397-406. PubMed ID: 27872526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer.
    Sheri A; Smith IE; Hills M; Jones RL; Johnston SR; Dowsett M
    Breast Cancer Res Treat; 2017 Jul; 164(2):395-400. PubMed ID: 28447240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy.
    Schneider J; Gonzalez-Roces S; Pollán M; Lucas R; Tejerina A; Martin M; Alba A
    Breast Cancer Res; 2001; 3(3):183-91. PubMed ID: 11305953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.